艾伯維公司
DE ˙ XTRA ˙ US00287Y1091
€188.50 ↑0.35 (0.19%)
2026-06-04
分享價格
SecurityDE:4AB / AbbVie Inc.
InstitutionPlimoth Trust Co Llc
Latest Disclosed Ownership18,845 shares
Latest Disclosed Value $ 4,098,599
Plimoth Trust Co Llc reports 2.39% decrease in ownership of 4AB / AbbVie Inc.

On April 27, 2026 - Plimoth Trust Co Llc filed a 13F-HR form disclosing ownership of 18,845 shares of AbbVie Inc. (DE:4AB) valued at $3,493,863 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 27, 2026 disclosing 19,307 shares of AbbVie Inc.. This represents a change in shares of -2.39% during the quarter. The current value of the position is $3,552,282 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-27 2026-03-31 13F AbbVie Com 00287Y109 18,845 -462 -2.39 4,099 -7.10 0.9161
2026-01-27 2025-12-31 13F AbbVie Com 00287Y109 19,307 -210 -1.08 4,411 -2.37 0.9829
2025-10-17 2025-09-30 13F AbbVie Com 00287Y109 19,517 -548 -2.73 4,519 21.32 1.0233
2025-07-22 2025-06-30 13F AbbVie Com 00287Y109 20,065 -208 -1.03 3,724 -12.31 0.8931
2025-04-21 2025-03-31 13F AbbVie Com 00287Y109 20,273 -22 -0.11 4,248 17.78 1.1065
2025-01-23 2024-12-31 13F AbbVie Com 00287Y109 20,295 -265 -1.29 3,606 -11.18 0.9262
2024-10-21 2024-09-30 13F AbbVie Com 00287Y109 20,560 -1,081 -5.00 4,060 9.40 1.0229
2024-07-23 2024-06-30 13F AbbVie Com 00287Y109 21,641 -4,664 -17.73 3,712 -22.53 0.9904
2024-04-18 2024-03-31 13F AbbVie Com 00287Y109 26,305 -1,987 -7.02 4,790 9.26 1.2763
2024-01-26 2023-12-31 13F AbbVie Com 00287Y109 28,292 -524 -1.82 4,384 2.07 1.2652
2023-10-20 2023-09-30 13F AbbVie Com 00287Y109 28,816 -434 -1.48 4,295 9.01 1.3452
2023-07-24 2023-06-30 13F AbbVie Com 00287Y109 29,250 129 0.44 3,941 -15.10 1.1789
2023-04-26 2023-03-31 13F AbbVie Com 00287Y109 29,121 712 2.51 4,641 115,925.00 1.4401
2023-01-19 2022-12-31 13F AbbVie Com 00287Y109 28,409 -1,092 -3.70 5 -99.90 1.4810
2022-10-18 2022-09-30 13F AbbVie Com 00287Y109 29,501 54 0.18 3,960 -12.20 1.3688
2022-07-15 2022-06-30 13F AbbVie Com 00287Y109 29,447 -1,328 -4.32 4,510 -9.60 1.4226
2022-04-25 2022-03-31 13F AbbVie Com 00287Y109 30,775 -235 -0.76 4,989 18.81 1.3254
2022-01-27 2021-12-31 13F AbbVie Com 00287Y109 31,010 547 1.80 4,199 27.78 1.0647
2021-10-22 2021-09-30 13F AbbVie Com 00287Y109 30,463 1,032 3.51 3,286 -0.87 0.9290
2021-07-20 2021-06-30 13F AbbVie Com 00287Y109 29,431 -1,605 -5.17 3,315 -1.31 0.9304
2021-04-14 2021-03-31 13F AbbVie Com 00287Y109 31,036 1,137 3.80 3,359 4.84 0.9912
2021-01-22 2020-12-31 13F AbbVie Com 00287Y109 29,899 -492 -1.62 3,204 20.36 1.0006
2020-10-27 2020-09-30 13F AbbVie Com 00287Y109 30,391 -984 -3.14 2,662 -13.57 0.8927
2020-07-20 2020-06-30 13F AbbVie Com 00287Y109 31,375 -850 -2.64 3,080 25.46 1.0953
2020-04-22 2020-03-31 13F AbbVie Com 00287Y109 32,225 -3,538 -9.89 2,455 -22.46 1.0295
2020-01-29 2019-12-31 13F AbbVie Com 00287Y109 35,763 -520 -1.43 3,166 15.21 1.0239
2019-10-28 2019-09-30 13F AbbVie Com 00287Y109 36,283 -4,204 -10.38 2,748 -6.66 0.9011
2019-08-05 2019-06-30 13F AbbVie Com 00287Y109 40,487 -2,769 -6.40 2,944 -15.55 0.9688
2019-04-19 2019-03-31 13F AbbVie Com 00287Y109 43,256 3,980 10.13 3,486 -3.73 1.1595
2019-01-25 2018-12-31 13F AbbVie Com 00287Y109 39,276 481 1.24 3,621 -1.31 1.3352
2018-12-13 2018-09-30 13F AbbVie Com 00287Y109 38,795 4,506 13.14 3,669 15.49 1.1891
2018-12-12 2018-06-30 13F AbbVie Com 00287Y109 34,289 -168 -0.49 3,177 -2.61 1.0887
2018-12-21 2018-03-31 13F AbbVie Com 00287Y109 34,457 2,189 6.78 3,262 4.52 1.1268
2018-12-26 2017-12-31 13F AbbVie Com 00287Y109 32,268 32,268 3,121 1.1179
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.